These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 28993105)

  • 21. GnRH Agonist and hCG (Dual Trigger) Versus hCG Trigger for Final Oocyte Maturation in Expected Normal Responders With a High Immature Oocyte Rate: Study Protocol for a Randomized, Superiority, Parallel Group, Controlled Trial.
    Yan MH; Cao JX; Hou JW; Jiang WJ; Wang DD; Sun ZG; Song JY
    Front Endocrinol (Lausanne); 2022; 13():831859. PubMed ID: 35418945
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproductive outcomes of dual trigger with combination GnRH agonist and hCG versus trigger with hCG alone in women undergoing IVF/ICSI cycles: a retrospective cohort study with propensity score matching.
    Dong L; Lian F; Wu H; Xiang S; Li Y; Wei C; Yu X; Xin X
    BMC Pregnancy Childbirth; 2022 Jul; 22(1):583. PubMed ID: 35869444
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D; Benadiva C; Kummer N; Budinetz T; Nulsen J; Engmann L
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A gonadotropin releasing hormone agonist trigger of ovulation with aggressive luteal phase support for patients at risk of ovarian hyperstimulation syndrome undergoing controlled ovarian hyperstimulation.
    Liang IT; Huang HY; Wu HM; Wang HS; Yu HT; Huang SY; Chang CL; Soong YK
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):583-7. PubMed ID: 26522115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does 'Dual Trigger' Increase Oocyte Maturation Rate?
    Ben-Haroush A; Sapir O; Salman L; Altman E; Garor R; Margalit T; Shufaro Y; Oron G
    J Obstet Gynaecol; 2020 Aug; 40(6):860-862. PubMed ID: 31790320
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Triggering of ovulation for GnRH-antagonist cycles in normal and low ovarian responders undergoing IVF/ICSI: A systematic review and meta-analysis of randomized trials.
    He FF; Hu W; Yong L; Li YM
    Eur J Obstet Gynecol Reprod Biol; 2023 Oct; 289():65-73. PubMed ID: 37639817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dual triggering with GnRH agonist plus hCG versus triggering with hCG alone for IVF/ICSI outcome in GnRH antagonist cycles: a systematic review and meta-analysis.
    Chen CH; Tzeng CR; Wang PH; Liu WM; Chang HY; Chen HH; Chen CH
    Arch Gynecol Obstet; 2018 Jul; 298(1):17-26. PubMed ID: 29600322
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GnRH agonist with low-dose hCG (dual trigger) is associated with higher risk of severe ovarian hyperstimulation syndrome compared to GnRH agonist alone.
    O'Neill KE; Senapati S; Maina I; Gracia C; Dokras A
    J Assist Reprod Genet; 2016 Sep; 33(9):1175-84. PubMed ID: 27349252
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The benefit of individualized low-dose hCG support for high responders in GnRHa-triggered IVF/ICSI cycles.
    Huang CY; Shieh ML; Li HY
    J Chin Med Assoc; 2016 Jul; 79(7):387-93. PubMed ID: 27147462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dual trigger improves the pregnancy rate in fresh in vitro fertilization (IVF) cycles compared with the human chorionic gonadotropin (hCG) trigger: a systematic review and meta-analysis of randomized trials.
    Hsia LH; Lee TH; Lin YH; Huang YY; Chang HJ; Liu YL
    J Assist Reprod Genet; 2023 Sep; 40(9):2063-2077. PubMed ID: 37466846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reproductive outcomes of dual trigger therapy with GnRH agonist and hCG versus hCG trigger in women with diminished ovarian reserve: a retrospective study.
    Chen K; Zhang C; Chen L; Zhao Y; Li H
    Reprod Biol Endocrinol; 2024 Apr; 22(1):35. PubMed ID: 38566172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel oocyte maturation trigger using 1500 IU of human chorionic gonadotropin plus 450 IU of follicle-stimulating hormone may decrease ovarian hyperstimulation syndrome across all in vitro fertilization stimulation protocols.
    Anaya Y; Mata DA; Letourneau J; Cakmak H; Cedars MI; Rosen MP
    J Assist Reprod Genet; 2018 Feb; 35(2):297-307. PubMed ID: 29086322
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combined GnRH-agonist and human chorionic gonadotropin trigger improves ICSI cycle outcomes in patients with history of poor fertilization.
    Elias RT; Pereira N; Artusa L; Kelly AG; Pasternak M; Lekovich JP; Palermo GD; Rosenwaks Z
    J Assist Reprod Genet; 2017 Jun; 34(6):781-788. PubMed ID: 28444614
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Triggering with 1,500 IU of human chorionic gonadotropin plus follicle-stimulating hormone compared to a standard human chorionic gonadotropin trigger dose for oocyte competence in in vitro fertilization cycles: a randomized, double-blinded, controlled noninferiority trial.
    Anaya Y; Cakmak H; Mata DA; Letourneau J; Zhang L; Lenhart N; Juarez-Hernandez F; Jalalian L; Cedars MI; Rosen M
    Fertil Steril; 2022 Aug; 118(2):266-278. PubMed ID: 35705380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dual trigger of final oocyte maturation with a combination of GnRH agonist and hCG versus a hCG alone trigger in GnRH antagonist cycle for in vitro fertilization: A Systematic Review and Meta-analysis.
    Ding N; Liu X; Jian Q; Liang Z; Wang F
    Eur J Obstet Gynecol Reprod Biol; 2017 Nov; 218():92-98. PubMed ID: 28957685
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GnRH triggering may improve euploidy and live birth rate in hyper-responders: a retrospective cohort study.
    Tan J; Jing C; Zhang L; Lo J; Kan A; Nakhuda G
    J Assist Reprod Genet; 2020 Aug; 37(8):1939-1948. PubMed ID: 32533431
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined ovulation triggering with GnRH agonist and hCG in IVF patients.
    Kasum M; Kurdija K; Orešković S; Čehić E; Pavičić-Baldani D; Škrgatić L
    Gynecol Endocrinol; 2016 Nov; 32(11):861-865. PubMed ID: 27275861
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual trigger with gonadotropin releasing hormone agonist and human chorionic gonadotropin improves live birth rates in POSEIDON group 3 and 4 expected poor responders.
    Tulek F; Kahraman A; Demirel LC
    Gynecol Endocrinol; 2022 Sep; 38(9):731-735. PubMed ID: 35856433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.